CRDL
Cardiol Therapeutics
CRDL
CRDL
28 hedge funds and large institutions have $8.27M invested in Cardiol Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $10.7M → $8.27M (-$2.46M)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Holders
28
Holding in Top 10
–
Calls
$1.88M
Puts
$105K
Top Buyers
| 1 | +$531K | |
| 2 | +$166K | |
| 3 | +$153K | |
| 4 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$114K |
| 5 |
RSWM
Robertson Stephens Wealth Management
San Francisco,
California
|
+$42K |
Top Sellers
| 1 | -$847K | |
| 2 | -$360K | |
| 3 | -$230K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$184K |
| 5 |
Renaissance Technologies
New York
|
-$171K |